The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Alligator Bioscience; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Lilly; Roche/Genentech; Tusk Therapeutics
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Lilly; Tusk Therapeutics
Research Funding - Alligator Bioscience; Bristol-Myers Squibb; Pfizer; Roche/Genentech
Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
 
Yoon-Koo Kang
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Lilly/ImClone; LSK Biopharma; Merck Serono; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - DAEHWA Pharmaceutical; LSK Biopharma
 
Tae-You Kim
No Relationships to Disclose
 
Anthony B. El-Khoueiry
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Merck; Novartis; Roche/Genentech
Consulting or Advisory Role - Agenus; AstraZeneca; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; MSD; Pfizer; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Celgene; Lilly; Novartis; Roche; Sandoz; Takeda
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; H3 Biomedicine; Ipsen; Lilly; Merck; Onxeo; Sirtex Medical
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Sirtex Medical (Inst)
 
Ignacio Melero
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Abbvie; Astellas Pharma; Chugai Pharma; Daiichi Sankyo; EA Pharma; Eisai; Gilead Sciences; MSD; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Eisai; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Ming-Mo Hou
No Relationships to Disclose
 
Ana Matilla
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Francesco Tovoli
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca; Merck
 
Aiwu Ruth He
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Genentech; Merck
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Regeneron
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Mirelis Acosta-Rivera
No Relationships to Disclose
 
Jaclyn Neely
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Yun Shen
Employment - Bristol-Myers Squibb; Sanofi (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Sanofi (I)
 
Carlos Baccan
Employment - Bristol-Myers Squibb; PAREXEL
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; PAREXEL
 
Christine Marie Dela Cruz
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Chiun Hsu
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; MSD Oncology; Roche/Genentech; TTY Biopharm
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical